Phase I dose-escalating study of docetaxel in combination with 5-day continuous infusion of 5-fluorouracil in patients with advanced gastric cancer

被引：0
作者：
Se Hoon Park
Soo-Mee Bang
Eun Kyung Cho
Dong Bok Shin
Jae Hoon Lee
Woon KI Lee
Min Chung
机构：
[1] Gachon Medical School Gil Medical Center,Division of Hematology and Oncology, Department of Internal Medicine
[2] Gachon Medical School Gil Medical Center,Department of General Surgery
来源：
BMC Cancer | / 5卷
关键词：
Gastric Cancer; Docetaxel; Dose Level; Febrile Neutropenia; Dose Escalation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial
    Gubanski, Michael
    Johnsson, Anders
    Fernebro, Eva
    Kadar, Lianna
    Karlberg, Ingegerd
    Flygare, Petra
    Berglund, Ake
    Glimelius, Bengt
    Lind, Pehr A.
    GASTRIC CANCER, 2010, 13 (03) : 155 - 161
  • [32] Phase I trial of escalating-dose cisplatin with 5-fluorouracil and concurrent radiotherapy in Chinese patients with esophageal cancer
    Lin, Qiang
    Gao, Xian-Shu
    Qiao, Xue-Ying
    Zhou, Zhi-Guo
    Zhang, Ping
    Chen, Kun
    Zhao, Yan-Nan
    Asaumi, Junichi
    ACTA MEDICA OKAYAMA, 2008, 62 (01) : 37 - 44
  • [33] A phase II study of paclitaxel, weekly, 24-hour continuous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer
    C Kollmannsberger
    D Quietzsch
    C Haag
    T Lingenfelser
    M Schroeder
    J T Hartmann
    W Baronius
    V Hempel
    M Clemens
    L Kanz
    C Bokemeyer
    British Journal of Cancer, 2000, 83 : 458 - 462
  • [34] A phase II study of paclitaxel, weekly, 24-hour continuous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer
    Kollmannsberger, C.
    Quietzsch, D.
    Haag, C.
    Lingenfelsers, T.
    Schroeder, M.
    Hartmann, J. T.
    Baronius, W.
    Hempel, V.
    Clemens, M.
    Kanz, L.
    Bokemeyer, C.
    BRITISH JOURNAL OF CANCER, 2000, 83 (04) : 458 - 462
  • [35] TREATMENT OF ELDERLY ADVANCED GASTRIC-CANCER PATIENTS WITH 5-FLUOROURACIL AND LEUCOVORIN COMBINATION
    CASCINU, S
    FEDELI, A
    FEDELI, SL
    CATALANO, G
    JOURNAL OF CHEMOTHERAPY, 1992, 4 (03) : 185 - 188
  • [36] Treatment of advanced gastric cancer with 5-fluorouracil and cisplatin in combination with dipyridamole
    Kohnoe, S
    Maehara, Y
    Takahashi, I
    Emi, Y
    Baba, H
    Sugimachi, K
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 13 (06) : 1203 - 1206
  • [37] Combination chemotherapy with 5-fluorouracil, cisplatin and paclitaxel for pretreated patients with advanced gastric cancer
    Yamaguchi, Kentaro
    Nakagawa, Satoru
    Yabusaki, Hiroshi
    Nashimoto, Atsushi
    ANTICANCER RESEARCH, 2007, 27 (5B) : 3535 - 3539
  • [38] Docetaxel, cisplatin, and 5-fluorouracil compared with epirubicin, cisplatin, and 5-fluorouracil regimen for advanced gastric cancer: A systematic review and meta-analysis
    Li, Bo
    Chen, Lian
    Luo, Hong-Liang
    Yi, Feng-Ming
    Wei, Yi-Ping
    Zhang, Wen-Xiong
    WORLD JOURNAL OF CLINICAL CASES, 2019, 7 (05) : 600 - 615
  • [39] Phase I study of Paclitaxel, Cisplatin and 5-fluorouracil combination chemotherapy for unresectable/recurrent gastric cancer
    Kato, J.
    Nagahara, A.
    Iijima, K.
    Kodani, T.
    Higashihara, Y.
    Yoshimura, M.
    Serizawa, N.
    Osada, T.
    Yoshizawa, T.
    Otaka, M.
    Watanabe, S.
    ADVANCES IN MEDICAL SCIENCES, 2010, 55 (02): : 137 - 142
  • [40] Randomized Phase III Study of 5-Fluorouracil Continuous Infusion vs. Sequential Methotrexate and 5-Fluorouracil Therapy in Far Advanced Gastric Cancer with Peritoneal Metastasis (JCOG0106)
    Shirao, Kuniaki
    Boku, Narikazu
    Yamada, Yasuhide
    Yamaguchi, Kensei
    Doi, Toshihiko
    Goto, Masahiro
    Nasu, Junichiro
    Denda, Tadamichi
    Hamamoto, Yasuo
    Takashima, Atsuo
    Fukuda, Haruhiko
    Ohtsu, Atsushi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (10) : 972 - 980
12345